Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maribavir in Chinese Transplant Recipients With Refractory or Resistant CMV Infections
NCT06439342Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2024
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
A Phase 3 trial of maribavir in cytomegalovirus infection (CMV), sponsored by Takeda. Started Dec 2024; status: completed.
02
Drugs
maribavir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT06439342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06439342.